Working… Menu
Trial record 9 of 11 for:    "Tyrosinemia type 1"

Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical Care (OPAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02320084
Recruitment Status : Completed
First Posted : December 19, 2014
Last Update Posted : November 6, 2019
Information provided by (Responsible Party):
Swedish Orphan Biovitrum

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 30, 2019
Actual Study Completion Date : September 30, 2019